{"id":62462,"date":"2026-01-08T16:05:58","date_gmt":"2026-01-08T15:05:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/"},"modified":"2026-01-08T16:05:58","modified_gmt":"2026-01-08T15:05:58","slug":"during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/","title":{"rendered":"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b><i>Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of the Media, and 1,200+ Investors<\/i><\/b><\/p>\n<p class=\"bwalignc\">\n<b><i>R<\/i><i>egistration and Partnering Platform Access Now Open<\/i><\/b><\/p>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/biotechshowcase?src=hash\" target=\"_blank\">#biotechshowcase<\/a>&#8211;More than 3,000 leaders within biotechnology are registered to attend <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finformaconnect.com%2Fbiotech-showcase&amp;esheet=54391435&amp;newsitemid=20260108192178&amp;lan=en-US&amp;anchor=Biotech+Showcase+2026&amp;index=1&amp;md5=c96920636a941ea906016f94729cc263\" rel=\"nofollow\" shape=\"rect\">Biotech Showcase 2026<\/a> during J.P. Morgan Healthcare Week for unmatched opportunity to forge critical investment and partnering relationships as well as industry and financial media covering the event. Hosted by <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdemy-colton.com%2F&amp;esheet=54391435&amp;newsitemid=20260108192178&amp;lan=en-US&amp;anchor=Demy-Colton&amp;index=2&amp;md5=04e69773c2ac5db5b5d7d0ba23393967\" rel=\"nofollow\" shape=\"rect\">Demy-Colton<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ebdgroup.com%2F&amp;esheet=54391435&amp;newsitemid=20260108192178&amp;lan=en-US&amp;anchor=EBD+Group&amp;index=3&amp;md5=cab3e578bccd54ab3b257fbf6734f5e1\" rel=\"nofollow\" shape=\"rect\">EBD Group<\/a>, the event returns to the Hilton San Francisco Union Square January 12-14, 2026. A virtual event extends access to networking and insights January 20-21, 2026. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finformaconnect.com%2Fbiotech-showcase%2Fregistration-options%2F&amp;esheet=54391435&amp;newsitemid=20260108192178&amp;lan=en-US&amp;anchor=Registration&amp;index=4&amp;md5=2922e47beca9a432f7f842d21cbce240\" rel=\"nofollow\" shape=\"rect\">Registration<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpartneringone.informaconnect.com%2Fevent%2F778%3F_gl%3D1*192olt0*_gcl_aw*R0NMLjE3NjYwMDY4MjMuQ2owS0NRaUF4b25LQmhDMUFSSXNBSUhxX2x1VlFISUkwTWRyM0d3TVFDVDh6LUpwZnNINVR1N1Z5emgzbnZVODRzMFZhWWFzR2gzMWlGZ2FBdmVIRUFMd193Y0I.*_gcl_au*MjY3MjU0NzU5LjE3NTk5Nzk2NzMuNjA3MDkxNDg1LjE3NjQ5NTI3MTYuMTc2NDk1Mjc3Mg..*_ga*MTYyMTgxNjQzNS4xNzU5OTc5Njc0*_ga_CM38S3JK2J*czE3Njc2MzUyNTMkbzQzJGcwJHQxNzY3NjM1MjUzJGo2MCRsMCRoMA..&amp;esheet=54391435&amp;newsitemid=20260108192178&amp;lan=en-US&amp;anchor=partnering&amp;index=5&amp;md5=2011c8c09baa19954e70c2efd7be0f78\" rel=\"nofollow\" shape=\"rect\">partnering<\/a> are now open for both.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/5\/Screenshot_2026-01-07_135925.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/22\/Screenshot_2026-01-07_135925.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/5\/Screenshot_2026-01-07_135925.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/21\/Screenshot_2026-01-07_135925.jpg\"><\/a><\/p>\n<p>\nSara Jane Demy, Founder &amp; CEO of Demy-Colton, said, \u201cWe anticipate renewed investment and dealmaking momentum in 2026, driven by rapid scientific advancement, evolving funding models, and the convergence of technology and biology. At the same time, policy changes are influencing how companies approach regulation, R&amp;D strategy, capital deployment, and partnering. This is our 18th year for Biotech Showcase, and we&#8217;re so pleased it\u2019s become a premier venue for dealmaking during JPM Week.\u201d<\/p>\n<p>\nBiotech Showcase attendees have the opportunity to:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nEngage in partnering and investment meetings among attending investors and pharma companies.<\/li>\n<li>\nGet to know emerging private and small-cap public biotech and TechBio companies through company presentations and partnering meetings.<\/li>\n<li>\nMeet with members of industry media including Endpoints, STAT, BioSpace, Fast Company, and others.<\/li>\n<li>\nJoin curated discussions with leaders from companies like Novo Nordisk, Astellas, J.P. Morgan, Regeneron, Ipsen, Stifel, Sofinnova Investments, Cellino, Envisagenics, Syneos Health, and Angelini Ventures, among many others.<\/li>\n<\/ul>\n<p>\nTina Elder, Global Managing Director, EBD Group US, said, \u201cAs the premier investor conference for private and micro- to mid-cap biotechnology companies, Biotech Showcase offers unmatched opportunities for networking, dealmaking, and partnering across biotech, pharma, and the global investment community. As the industry looks toward 2026, Biotech Showcase provides a timely forum for engaging with the companies and leaders driving the industry\u2019s evolution, offering direct exposure to emerging science, differentiated platforms, and the TechBio capabilities now essential to competitive drug development.\u201d<\/p>\n<p>\n<b><span class=\"bwuline\">Opening day highlights<\/span><\/b>:<\/p>\n<p>\n<b>Healthcare Innovation: Strategic Adaption to the New Policy Landscape<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Michael Margolis<\/b> &#8211; Senior Managing Director, Head, Healthcare Investment Banking, Oppenheimer &amp; Co. Inc.<\/li>\n<li>\n<b>Thomas Barker<\/b> &#8211; Partner, Co-Chair, Healthcare Department, Foley Hoag<\/li>\n<li>\n<b>Fritz Bittenbender<\/b> &#8211; Board Chair, BIO &amp; SVP, Genentech<\/li>\n<li>\n<b>Jeremy Levin<\/b> &#8211; Chairman &amp; CEO, Ovid Therapeutics Inc.<\/li>\n<li>\n<b>Lori Reilly<\/b> &#8211; COO, PhRMA<\/li>\n<li>\n<b>Joe Shonkwiler<\/b> &#8211; Head, Healthcare &amp; Life Science, Venture Capital BD, Google<\/li>\n<\/ul>\n<p>\n<b>The 2026 Pharma Perspective: Dealmaking Driving Therapeutic Development<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>David Schull<\/b> &#8211; President, Russo Partners<\/li>\n<li>\n<b>Tamara Darsow<\/b> &#8211; SVP, Global Business Development, Novo Nordisk<\/li>\n<li>\n<b>David Jenkins<\/b> &#8211; SVP, Head, External Innovation and Research, Ipsen<\/li>\n<li>\n<b>Amanda Kay<\/b> &#8211; Senior Partner &amp; Chief Business Development Officer, Flagship Pioneering<\/li>\n<li>\n<b>Adam Pearson<\/b> &#8211; Chief Strategy Officer, Astellas<\/li>\n<li>\n<b>Konstantina Katcheves<\/b> &#8211; SVP &amp; Chief Business and Strategy Officer, Acadia Pharmaceuticals<\/li>\n<\/ul>\n<p>\n<b>New Breakthroughs in Drug Discovery &amp; Target Identification<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Ignacio Guerrero-Ros <\/b>&#8211; VP, Russo Partners<\/li>\n<li>\n<b>Sean Lin <\/b>&#8211; CEO, ChemLex<\/li>\n<li>\n<b>Ravit Netzer <\/b>&#8211; Co-Founder &amp; CEO, Scala Biodesign<\/li>\n<li>\n<b>Ritish Patnaik <\/b>&#8211; CEO, Curve Biosciences<\/li>\n<li>\n<b>Cameron Pye <\/b>&#8211; Co-Founder &amp; CEO, Unnatural Products Inc.<\/li>\n<li>\n<b>Adrian Woolfson <\/b>&#8211; Founder, President &amp; CEO, Genyro<\/li>\n<\/ul>\n<p>\n<b><span class=\"bwuline\">Closing day highlights<\/span><\/b>:<\/p>\n<p>\n<b>Media Round-Up: Heard Around the Hilton<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Virginia Amann<\/b> &#8211; CEO &amp; Founder, ENTENTE Network<\/li>\n<li>\n<b>Alex Philippidis<\/b> &#8211; Senior Business Editor, GEN<\/li>\n<li>\n<b>Allison DeAngelis <\/b>&#8211; Reporter, Biotech Startups &amp; Venture Capital, STAT News<\/li>\n<li>\n<b>Ron Leuty<\/b> &#8211; Senior Reporter, San Francisco Business Times<\/li>\n<li>\n<b>Kyle LaHucik<\/b> &#8211; Senior Reporter, Endpoints News<\/li>\n<li>\n<b>Annalee Armstrong<\/b> &#8211; Senior Editor, BioSpace<\/li>\n<\/ul>\n<p>\nFor information about registering for Biotech Showcase or to apply to present or sponsor, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finformaconnect.com%2Fbiotech-showcase%2F&amp;esheet=54391435&amp;newsitemid=20260108192178&amp;lan=en-US&amp;anchor=www.informaconnect.com%2Fbiotech-showcase%2F&amp;index=6&amp;md5=ef676b300edcee62945407a0ea20e7cd\" rel=\"nofollow\" shape=\"rect\">www.informaconnect.com\/biotech-showcase\/<\/a>.<\/p>\n<p>\n<b>About Demy-Colton<\/b><\/p>\n<p>\nDemy-Colton is a leading life sciences and digital health events organization at the forefront of building networks between innovative life sciences companies and industry stakeholders. Its unique events facilitate networking on a global scale, including Biotech Showcase\u2122, BioFuture\u2122, Global Biotech CEO Summit\u2122, Executive Clinics\u2122, and Demy-Colton Virtual Salons\u2122. These events build networking communities that transcend geographical boundaries and establish ongoing, high-value relationships among the industry\u2019s top decision-makers, investors and thought leaders. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdemy-colton.com%2F&amp;esheet=54391435&amp;newsitemid=20260108192178&amp;lan=en-US&amp;anchor=www.demy-colton.com&amp;index=7&amp;md5=1e59cc45ca30cfa8105dac612b361799\" rel=\"nofollow\" shape=\"rect\">www.demy-colton.com<\/a>.<\/p>\n<p>\n<b>About Life Sciences Partnering and Investment by Informa<\/b><\/p>\n<p>\nOur mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE\u00ae, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. Today, our events (BIO-Europe\u00ae, BIO-Europe Spring\u00ae, Biotech Showcase\u2122, ChinaBio\u00ae Partnering Forum, Asia Bio Partnering Forum, BioEquity Europe, LSX USA Congress, Investival Showcase Europe, European Lifestars Awards, Investival Showcase USA, LSX Europe Congress, LSX Nordic Congress) annually attract more than 14,000 senior life science executives who engage in over 83,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nKatie Morris<br \/>\n<br \/>ENTENTE Network of Companies<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#107;&#x61;&#116;&#x69;&#101;&#x6d;o&#x72;r&#105;&#x73;&#64;&#x65;n&#x74;e&#x6e;&#x74;&#101;&#x69;&#110;&#x63;&#46;&#x63;o&#109;\" rel=\"nofollow\" shape=\"rect\">&#107;&#x61;&#116;&#x69;&#101;&#x6d;o&#x72;r&#x69;s&#64;&#x65;&#110;&#x74;&#101;&#x6e;&#116;&#x65;i&#x6e;c&#x2e;c&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of the Media, and 1,200+ Investors Registration and Partnering Platform Access Now Open SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#biotechshowcase&#8211;More than 3,000 leaders within biotechnology are registered to attend Biotech Showcase 2026 during J.P. Morgan Healthcare Week for unmatched opportunity to forge &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62462","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of the Media, and 1,200+ Investors Registration and Partnering Platform Access Now Open SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#biotechshowcase&#8211;More than 3,000 leaders within biotechnology are registered to attend Biotech Showcase 2026 during J.P. Morgan Healthcare Week for unmatched opportunity to forge ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-08T15:05:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/22\/Screenshot_2026-01-07_135925.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media\",\"datePublished\":\"2026-01-08T15:05:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/\"},\"wordCount\":866,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260108192178\\\/en\\\/2685559\\\/22\\\/Screenshot_2026-01-07_135925.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/\",\"name\":\"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260108192178\\\/en\\\/2685559\\\/22\\\/Screenshot_2026-01-07_135925.jpg\",\"datePublished\":\"2026-01-08T15:05:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260108192178\\\/en\\\/2685559\\\/22\\\/Screenshot_2026-01-07_135925.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260108192178\\\/en\\\/2685559\\\/22\\\/Screenshot_2026-01-07_135925.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/","og_locale":"en_US","og_type":"article","og_title":"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media - Pharma Trend","og_description":"Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of the Media, and 1,200+ Investors Registration and Partnering Platform Access Now Open SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#biotechshowcase&#8211;More than 3,000 leaders within biotechnology are registered to attend Biotech Showcase 2026 during J.P. Morgan Healthcare Week for unmatched opportunity to forge ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/","og_site_name":"Pharma Trend","article_published_time":"2026-01-08T15:05:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/22\/Screenshot_2026-01-07_135925.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media","datePublished":"2026-01-08T15:05:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/"},"wordCount":866,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/22\/Screenshot_2026-01-07_135925.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/","url":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/","name":"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/22\/Screenshot_2026-01-07_135925.jpg","datePublished":"2026-01-08T15:05:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/22\/Screenshot_2026-01-07_135925.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260108192178\/en\/2685559\/22\/Screenshot_2026-01-07_135925.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"During J. P. Morgan Healthcare Week, Biotech Showcase\u2122 Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62462"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62462\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}